Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2013 4
2014 9
2015 8
2016 5
2017 9
2018 7
2019 5
2020 5
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort study.
Seko Y, Yamaguchi K, Shima T, Iwaki M, Takahashi H, Kawanaka M, Tanaka S, Mitsumoto Y, Yoneda M, Nakajima A, Fjellström O, Blau JE, Carlsson B, Okanoue T, Itoh Y. Seko Y, et al. Among authors: tanaka s. Liver Int. 2023 Oct;43(10):2210-2219. doi: 10.1111/liv.15678. Epub 2023 Jul 20. Liver Int. 2023. PMID: 37470077
Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes.
Ishiba H, Sumida Y, Seko Y, Tanaka S, Yoneda M, Hyogo H, Ono M, Fujii H, Eguchi Y, Suzuki Y, Yoneda M, Takahashi H, Nakahara T, Mori K, Kanemasa K, Shimada K, Imajo K, Yamaguchi K, Kawaguchi T, Nakajima A, Chayama K, Shima T, Fujimoto K, Okanoue T, Itoh Y; Japan Study Group of NAFLD. Ishiba H, et al. Among authors: tanaka s. Hepatol Commun. 2020 Nov 16;5(4):559-572. doi: 10.1002/hep4.1637. eCollection 2021 Apr. Hepatol Commun. 2020. PMID: 33860115 Free PMC article.
Infection phase is a predictor of pruritus in patients with hepatitis B virus infection.
Oeda S, Takahashi H, Isoda H, Komukai S, Imajo K, Yoneda M, Ono M, Hyogo H, Kawaguchi T, Fujii H, Kawanaka M, Sumida Y, Tanaka S, Kawamoto H, Torimura T, Saibara T, Kawaguchi A, Nakajima A, Eguchi Y. Oeda S, et al. Among authors: tanaka s. Biomed Rep. 2019 Aug;11(2):63-69. doi: 10.3892/br.2019.1224. Epub 2019 Jun 21. Biomed Rep. 2019. PMID: 31338192 Free PMC article.
Prevalence of pruritus in patients with chronic liver disease: A multicenter study.
Oeda S, Takahashi H, Yoshida H, Ogawa Y, Imajo K, Yoneda M, Koshiyama Y, Ono M, Hyogo H, Kawaguchi T, Fujii H, Nishino K, Sumida Y, Tanaka S, Kawanaka M, Torimura T, Saibara T, Kawaguchi A, Nakajima A, Eguchi Y; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Oeda S, et al. Among authors: tanaka s. Hepatol Res. 2018 Feb;48(3):E252-E262. doi: 10.1111/hepr.12978. Epub 2017 Oct 10. Hepatol Res. 2018. PMID: 28877392
Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver disease.
Tada T, Saibara T, Ono M, Takahashi H, Eguchi Y, Hyogo H, Kawanaka M, Kumada T, Toyoda H, Yasuda S, Nakajima A, Yoneda M, Tanaka S, Shimada K, Hoshino H, Aishima S, Kage M, Sumida Y. Tada T, et al. Among authors: tanaka s. Eur J Gastroenterol Hepatol. 2021 Nov 1;33(11):1451-1458. doi: 10.1097/MEG.0000000000002176. Eur J Gastroenterol Hepatol. 2021. PMID: 34334708
Differential effects of genetic polymorphism on comorbid disease in metabolic dysfunction-associated steatotic liver disease.
Seko Y, Yamaguchi K, Shima T, Iwaki M, Takahashi H, Kawanaka M, Tanaka S, Mitsumoto Y, Yoneda M, Nakajima A, Okanoue T, Itoh Y. Seko Y, et al. Among authors: tanaka s. Clin Gastroenterol Hepatol. 2024 Apr 9:S1542-3565(24)00311-2. doi: 10.1016/j.cgh.2024.02.031. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38604296
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis.
Kodama K, Kawaguchi T, Hyogo H, Nakajima T, Ono M, Seike M, Takahashi H, Nozaki Y, Kawanaka M, Tanaka S, Imajo K, Sumida Y, Kamada Y, Fujii H, Seko Y, Takehara T, Itoh Y, Nakajima A, Masaki N, Torimura T, Saibara T, Karino Y, Chayama K, Tokushige K. Kodama K, et al. Among authors: tanaka s. J Gastroenterol Hepatol. 2019 Sep;34(9):1626-1632. doi: 10.1111/jgh.14608. Epub 2019 Mar 6. J Gastroenterol Hepatol. 2019. PMID: 30668889
HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.
Fujii H, Imajo K, Yoneda M, Nakahara T, Hyogo H, Takahashi H, Hara T, Tanaka S, Sumida Y, Eguchi Y, Chayama K, Nakajima A, Nishimoto N, Kawada N; Japan Study Group of Nonalcoholic Fatty Liver Disease. Fujii H, et al. Among authors: tanaka s. J Gastroenterol Hepatol. 2019 Aug;34(8):1390-1395. doi: 10.1111/jgh.14595. Epub 2019 Feb 3. J Gastroenterol Hepatol. 2019. PMID: 30600551
Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.
Kawaguchi T, Shima T, Mizuno M, Mitsumoto Y, Umemura A, Kanbara Y, Tanaka S, Sumida Y, Yasui K, Takahashi M, Matsuo K, Itoh Y, Tokushige K, Hashimoto E, Kiyosawa K, Kawaguchi M, Itoh H, Uto H, Komorizono Y, Shirabe K, Takami S, Takamura T, Kawanaka M, Yamada R, Matsuda F, Okanoue T. Kawaguchi T, et al. Among authors: tanaka s. PLoS One. 2018 Jan 31;13(1):e0185490. doi: 10.1371/journal.pone.0185490. eCollection 2018. PLoS One. 2018. PMID: 29385134 Free PMC article.
43 results